Mirae Asset Global ETFs Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.8M Sell
1,203,403
-200,533
-14% -$5.34M 0.05% 356
2025
Q4
$35M Buy
1,403,936
+335,515
+31% +$8.46M 0.05% 325
2025
Q3
$27.1M Sell
1,068,421
-133,898
-11% -$3.3M 0.04% 379
2025
Q2
$29.1M Buy
1,202,319
+91,027
+8% +$2.12M 0.06% 312
2025
Q1
$28.2M Buy
1,111,292
+20,518
+2% +$537K 0.06% 301
2024
Q4
$28.9M Buy
1,090,774
+82,594
+8% +$2.24M 0.06% 308
2024
Q3
$29.2M Sell
1,008,180
-88,433
-8% -$2.58M 0.07% 293
2024
Q2
$30.7M Buy
+1,096,613
New +$30.2M 0.07% 267

Other funds holding PFE

Mirae Asset Global ETFs Holdings's PFE Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Pfizer (PFE) stake by 14% in Q1 2026, selling an estimated $5.34M and leaving 1,203,403 shares worth $33.8M. The position accounts for 0.05% of the portfolio, ranked #356.

Mirae Asset Global ETFs Holdings first reported a position in PFE in Q2 2024 and has held it in 8 quarters since. The position peaked at $35M in Q4 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 1,203,403 shares of Pfizer worth $33.8M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 200,533 Pfizer shares in Q1 2026, an estimated $5.34M.
  • Pfizer made up 0.05% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #356 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Pfizer in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Pfizer position peaked at $35M in Q4 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.